Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 4, 2011, Pages

  Balashov, Dmitry N ^a   Papusha, Ludmila I ^a   Nazarenko, Tatiana A ^b   Trakhtman, Pavel E ^a   Revishvili, Nino A ^b   Maschan, Alexei A ^a   Persiantseva, Marina I ^a   Andriutsa, Anna V ^b   Skorobogatova, Elena V ^a   Skvortsova, Yulia V ^a   Rumiantsev, Alexander G ^a  

^a Federal Research Center of Pediatric Hematology   (Russian Federation)

^b RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

acute myeloid leukemia; busulphan; ovarian function; pregnancy; Stem cell transplantation

Indexed keywords

ANTHRACYCLINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; ETOPOSIDE; FLUDARABINE; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AMENORRHEA; ANALYTICAL PARAMETERS; ANTRAL FOLLICLE COUNT; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FETUS HEART RATE; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; LOCAL SKIN REACTION; LOW DRUG DOSE; MYELOABLATIVE CONDITIONING; OVARY FUNCTION; PREGNANCY; PRIORITY JOURNAL; RADIATION DOSE; TRIPLOIDY; VAGINA BLEEDING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BUSULFAN; CHILD; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOGONADISM; LEUKEMIA, MYELOID, ACUTE; MYELOABLATIVE AGONISTS; OVARY; PREGNANCY; PREGNANCY OUTCOME; RECOVERY OF FUNCTION; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 79955521400     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181faf7b5     Document Type: Article

References (9)

1. Tauchmanovà L, Selleri C, De Rosa G, et al. Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review. Menopause. 2007;14:320-330 (Pubitemid 46673485)
2. Tauchmanovà L, Selleri C, De Rosa G, et al. Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. Hum Reprod. 2003;18:1410-1416. (Pubitemid 36840946)
3. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007;110:2222-2229. (Pubitemid 350100744)
4. Borgna-Pignatti C, Marradi P, Rugolotto S, et al. Successful pregnancy after bone marrow transplantation for thalassaemia. Bone Marrow Transplant. 1996;18:235-236. (Pubitemid 26289664)
5. Liu J, Malhotra R, Voltarelli J, et al. Ovarian recovery after stem cell transplantation. Bone Marrow Transplantation. 2008;41:275-278. (Pubitemid 351260382)
6. Remérand G, Merlin E, Froissart R, et al. Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation. J Inherit Metab Dis. 2009. [e-pub ahead of print 13 Mar 2009; doi: 1007/s10545-009-1095-y].
7. van Beek RD, van den Heuvel-Eibrink MM, Laven JS, et al. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metabolism. 2007;92:3869-3874. (Pubitemid 47607635)
8. Johnson J, Canning J, Kaneko T, et al. Germ-line stem cells and follicular repopulation in postnatal mammalian ovary. Nature. 2004;428:145-150. (Pubitemid 38374304)
9. Salooja N, Szydlo RM, Socie G, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;358:271-276. (Pubitemid 32738965)